搜索结果

Search Results for " narcolepsy "

如果没找到您满意的产品或者您对产品有其他要求，可以联系我们专业顾问为您提供针对性的合理建议。 QQ咨询网站留言咨询

Cat. No.	Product Name	Target	Signaling Pathways
T4262	BisfluoroModafinil	Dopamine Receptor	GPCR/G Protein; Neuroscience
	BisfluoroModafinil 是一种莫达非的常见替代品，具有增强认知能力的潜力。其中莫达非尼通常用于研究性嗜睡症。
T2613	Almorexant 阿莫伦特,ACT 078573	OX Receptor	GPCR/G Protein; Neuroscience
	Almorexant (ACT 078573) 是一种有效的竞争性食欲素 1 受体 (OX1)/食欲素 2 受体 (OX2) 双重拮抗剂，OX1 和 OX2 的 Ki 值分别为 1.3 和 0.17 nM。
T6155	Almorexant hydrochloride ACT-078573 hydrochloride,Almorexant HCl	OX Receptor	GPCR/G Protein; Neuroscience
	Almorexant hydrochloride (ACT-078573 hydrochloride) 是一种有效的竞争性食欲素 1 受体(OX1)/食欲素 2 受体 (OX2) 双重拮抗剂，OX1 和 OX2 的 Ki 值分别为 1.3 和 0.17 nM。
T39229	YNT-185	OX Receptor	GPCR/G Protein; Neuroscience
	YNT-185 is a nonpeptide, selective agonist of the orexin type-2 receptor (OX2R), demonstrating EC50 values of 0.028 μM and 2.75 μM for OX2R and OX1R, respectively. Furthermore, YNT-185 effectively alleviates symptoms of narcolepsy-cataplexy in mouse models.
T9770	Samelisant SUVN-G3031	Histamine Receptor	GPCR/G Protein; Immunology/Inflammation; Neuroscience
	Samelisant (SUVN-G3031) 是 H3 受体的特异性反向激动剂，对人和大鼠的 Kis 分别为 8.7 nM 和 9.8 nM。 Samelisant 具有抗猝倒作用，可用于关于发作性睡病的研究。
T19628	GSK 189254 HCl GSK-189254A,GSK 189254A,GSK 189254 hydrochloride,GSK189254A
	GSK 189254A is a histamine H3 receptor antagonist for the treatment of narcolepsy. Histamine H3 receptor antagonists have been shown to increase the release of neurotransmitters in the brain and to enhance cognition in vivo. The compound may also be usefu
T78636	Firazorexton hydrate TAK-994
	Firazorexton hydrate (TAK-994)为一种高效的食欲素2型受体(OX2R)激动剂，EC50值为19 nM。在发作性睡病小鼠模型中，该化合物能够有效减少觉醒碎片和猝倒样发作的发生。
T37112	YNT-185 dihydrochloride
	Potent and selective orexin OX2 receptor agonist (EC50 = 28 nM at human OX2 expressed in CHO cells). Displays approximately 100-fold selectivity for OX2 over OX1 (EC50 = 2.75 μM at human OX1 expressed in CHO cells). Depolarizes OX2-expressing histaminergic neurons in mouse brain slices. Increases wake time in wild type mice. Suppresses cataplexy-like symptoms in OX knockout mice. Nagahara et al (2015) Design and synthesis of non-peptide, selective orexin receptor 2 agonists. J.Med.Chem. 58 7931 ...